期刊文献+

真武汤重用茯苓治疗心肌病心力衰竭174例疗效观察 被引量:18

下载PDF
导出
摘要 目的探讨真武汤重用茯苓治疗心肌病心力衰竭的临床疗效。方法选取心肌病心衰患者174例,治疗组86例,对照组88例,两组均予西医常规疗法,治疗组加用真武汤重用茯苓方剂,早中晚餐前口服50ml,连续治疗2周。观察两组治疗前后临床疗效、并发症及生活质量的改善情况;检查左室射血分数(LVEF)及左室舒张末径(LVEDD)的变化。结果真武汤重用茯苓配合西医常规治疗总有效率达94%,较单纯以西医常规治疗的疗效差异有显著性(P<0.05),治疗前后LVEF均有不同程度增加,LVEDD缩小。结论真武汤重用茯苓配合西医治疗心肌病心衰疗效显著。
出处 《中国临床医生杂志》 2013年第11期66-67,共2页 Chinese Journal For Clinicians
基金 河北省中医药管理局2012年度中医药类科研计划课题(2012244)
  • 相关文献

参考文献3

  • 1王立军,马虹.心肌病新的定义及分类[J].国际内科学杂志,2007,34(12):712-715. 被引量:4
  • 2孙传兴.临床疾病诊断依据治愈好转标准[M]第2版[M].北京:人民军医出版社,1998.41-182.
  • 3M aron B J, Towb in JA, Thiene G, et al. Contemporary definitions and classification of the cardiomyopathies : an American heart association scientific statement from the councilon clinical cardiology, heart fail- ure and transpiantation committee ; quality of care and outcomes re- search and functional genomics and translational biology interdiscipli- nary working groups; and councilon epidemiology and prevention. Circulation, 2006,113 (4) : 1807-1816.

二级参考文献3

  • 1Maron BJ, Towbin JA, Thiene G, et al. Contemporary definitions and classification of the cardiomyopathies : an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation, 2006,113 (4) : 1807-1816.
  • 2Baughman KL. Diagnosis of myocarditis : death of Dallas criteria. Circulation, 2006,113 (4) :593-595.
  • 3Herskowitz A, Ahmed-Ansari A, Neumann DA, et al. Induction of major histocompatibility complex antigens within the myocardium of patients with active myocarditis: a nonhistologic marker of myocarditis. J Am Coll Cardiol, 1990, 15 (3) :624-632.

共引文献165

同被引文献200

引证文献18

二级引证文献200

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部